| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 8,806,000 | 15,961,000 | 17,601,000 | | Cost of Revenue |
-
| 4,577,000 |
-
| | | Gross Profit | 8,806,000 | 11,384,000 | 17,601,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 11,010,000 | 3,305,000 | 6,544,000 | | Non Recurring |
-
|
-
|
-
| | Others | 2,104,000 | 649,000 | 171,000 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,308,000) | 7,430,000 | 10,886,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,308,000) | 7,430,000 | 10,886,000 | | Interest Expense | 3,549,000 | 8,077,000 | 8,149,000 | | Income Before Tax | (7,857,000) | (647,000) | 2,737,000 | | Income Tax Expense | (714,000) | 32,000 | 1,241,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,143,000) | (679,000) | 1,496,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,143,000) | (679,000) | 1,496,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,143,000) | ($679,000) | $1,496,000 |
|
0.10% Nasdaq 
Income Statement
